holoxan 1 g
baxter oncology gmbh - germania - ifosfamidum - pulb. pt. sol. perf. - 1g - agenti alchilanti analogi de nitrogen mustard
physioneal 40 glucoza 38,6 mg/ml
baxter healthcare sa - irlanda - combinatii - sol. pt. dial. perit. - 38,6g/l - preparate pentru dializa peritoneala solutii hipertone
periolimel n4e
baxter s.a. - belgia - combinatii - emulsie perf. - solutii pentru administrare intravenoasa solutii pentru alimentatie parenterala
olimel n7e
baxter s.a. - belgia - combinatii - emulsie perf. - solutii pentru administrare intravenoasa solutii pentru alimentatie parenterala
olimel n9e
baxter s.a. - belgia - combinatii - emulsie perf. - solutii pentru administrare intravenoasa solutii pentru alimentatie parenterala
olimel n9
baxter s.a. - belgia - combinatii - emulsie perf. - solutii pentru administrare intravenoasa solutii pentru alimentatie parenterala
olimel n12e
baxter s.a. - belgia - combinatii - emulsie perf. - solutii pentru administrare intravenoasa solutii pentru alimentatie parenterala
suprane 100%
baxter s.a. - belgia - desfluranum - lichid pt. vapori de inhal. - 100% - anestezice generale derivati halogenati ai hidrocarburilor
celdoxome pegylated liposomal
yes pharmaceutical development services gmbh - doxorubicină clorhidrat - breast neoplasms; ovarian neoplasms; multiple myeloma; sarcoma, kaposi - agenți antineoplazici - celdoxome pegylated liposomal is indicated in adults:as monotherapy for patients with metastatic breast cancer, where there is an increased cardiac risk. or treatment of advanced ovarian cancer in women who have failed a first-line platinum-based chemotherapy regimen. in combination with bortezomib for the treatment of progressive multiple myeloma in patients who have received at least one prior therapy and who have already undergone or are unsuitable for bone marrow transplant. for treatment of aids-related kaposi’s sarcoma (ks) in patients with low cd4 counts (< 200 cd4 lymphocytes/mm3) and extensive mucocutaneous or visceral disease. celdoxome pegylated liposomal may be used as first-line systemic chemotherapy, or as second line chemotherapy in aids-ks patients with disease that has progressed with, or in patients intolerant to, prior combination systemic chemotherapy comprising at least two of the following agents: a vinca alkaloid, bleomycin and standard doxorubicin (or other anthracycline).
pandemic influenza vaccine h5n1 baxter ag
resilience biomanufacturing ireland limited - (virion întreg, inactivat) care conține antigenul: a / vietnam / 1203/2004 (h5n1) - influenza, human; immunization; disease outbreaks - vaccinuri - profilaxia gripei într-o situație pandemică declarată oficial. vaccinul antigripal pandemic trebuie utilizat în conformitate cu orientările oficiale.